Corticosteroids in Severe COVID-19(ASAP-C Study)

NCT04648410 | Unknown

• 1 other identifier: ASAP-C study
• Study Type: observational
• Target: 2,000
• Locations: 1 country
• Sites: 1

Brief Summary

Administration of systemic corticosteroids for patients with severe forms of severe acute respiratory syndrome(SARS-Co-2) infection are recommended by several guidelines. In the very beginning of SARS-Co-2 pandemic the early recommendation by professional organization was against routine use of corticosteroids for patients with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS), despite previous data and clinical practice for patients with refractory or severe form of ARDS.

Conditions

Severe COVID-19

Outcome Measures

Primary Outcomes (1)

• Systemic corticosteroids among patients with COVID-19 ARDS practice - questionnaire (electronic survey)

  Administration of systemic corticosteroids among patients with COVID-19 ARDS practice in European countries - questionnaire (electronic survey)

  1 month

Study Arms (1)

Members of European Society of Intensive Care

Members of European Society of Intensive Care will obtain an electronic survey considering their routine clinical practice regarding the administration of systemic corticosteroids among patients with COVID-19 ARDS

Other: questionnaire

Interventions

questionnaire OTHER

Members of European Society of Intensive Care will obtain an electronic survey considering their routine clinical practice regarding the administration of systemic corticosteroids among patients with COVID-19 ARDS

Also known as: survey

Members of European Society of Intensive Care

Eligibility Criteria

• Age: 28 Days - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Members of European Society of Intensive Care

You may qualify if:

• Members of European Society of Intensive Care

You may not qualify if:

• not members of European Society of Intensive Care

Sponsors & Collaborators

• Brno University Hospital: lead

Study Sites (1)

University Hospital Brno

Brno, 62500, Czechia

RECRUITING

MeSH Terms

Conditions

COVID-19

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Jan Malaska, MD., Ph.D

  University Hospital Brno

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Jan Malaska, MD., Ph.D

CONTACT

532232009; jan.malaska@gmail.com

Jozef Klučka, assoc.Prof.MD, Ph.D

CONTACT

532234696; klucka.jozef@fnbrno.cz

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: assoc.prof.MD,Ph.D

Study Record Dates

• First Submitted: November 26, 2020
• First Posted: December 1, 2020
• Study Start: February 16, 2021
• Primary Completion: September 30, 2023
• Study Completion: December 1, 2023
• Last Updated: July 27, 2023

Record last verified: 2023-07

Locations

CZ (1)